Table 2.
Definitions of severe complications in the primary outcome measure
| Severe complication | Criteria |
|---|---|
| Cholangitis | Elevation in temperature more than 38,5°C and Leukocytes ≥10 *109/L, thought to have a biliary cause, without concomitant evidence of acute cholecystitis, requiring invasive intervention. |
| Acute cholecystitis | Radiologic evidence of cholecystitis, elevation in temperature more than 38.5°C and Leukocytes ≥10*109/L, and requirement of percutaneous drainage or emergency cholecystectomy. |
| Stent/ catheter dysfunction | Rising bilirubin level after therapeutic success had initially been obtained, without signs of cholangitis or cholecystitis, requiring new cannulation of the tumor. |
| Acute pancreatitis | Abdominal pain and a serum concentration of pancreatic enzymes (amylase or lipase) ≥3 times the upper limit of normal, that requires ≥1 one night of hospitalization. |
| Hemorrhage | Clinical evidence of bleeding with the need of a blood transfusion. |
| Perforation | Retroperitoneal or bowel-wall perforation documented by any radiographic technique requiring intervention. |
| Portal vein thrombosis | Clinical evidence of thrombosis confirmed on colour Doppler US as absence of flow compatible with occlusion, precluding liver surgery. |
| Dehydration | Severe dehydration with electrolyte disturbances resulting from excessive fluid loss through externally draining catheters, requiring rehydration in the clinical setting. |